Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin add-on for double J stent symptoms after ureteroscopic treatment of ureteral stones
IRCT20170417033489N8Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of gabapentin in ureterolithiasis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Stimulus/irritative symptoms. Started Jun 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20170417033489N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170417033489N8.